ADK — Diagnos Cashflow Statement
0.000.00%
Last trade - 00:00- CA$30.95m
- CA$33.52m
- CA$0.17m
Annual cashflow statement for Diagnos, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.38 | -2.05 | -2.61 | -2.48 | -3.12 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.626 | 0.279 | 0.457 | 0.29 | 0.433 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.014 | 0.323 | 0.008 | 0.205 | 0.416 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.64 | -1.36 | -2.04 | -1.88 | -2.15 |
| Capital Expenditures | -0.015 | -0.042 | -0.031 | -0.024 | -0.011 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.745 | 0.305 | 0.535 | 0.499 | -0.003 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.76 | 0.263 | 0.504 | 0.475 | -0.014 |
| Financing Cash Flow Items | -0.034 | -0.018 | -0.023 | -0.118 | -0.263 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.83 | 0.883 | 1.6 | 1.28 | 2.08 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.432 | -0.211 | 0.062 | -0.124 | -0.078 |